← Open Payments lookup

JULIE HAUSNER: Open Payments

NPI 1952655482 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$579 in 26 payments from 12 companies in 2025. Trend: 2023 $520 · 2024 $574 · 2025 $579

Food & beverage: $579
CompanyPaymentsAmount
Gilead Sciences, Inc.5$113
Mallinckrodt Hospital Products Inc.5$113
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$80
Madrigal Pharmaceuticals3$75
Azurity Pharmaceuticals, Inc.2$57
Ethicon US, LLC1$43
Intercept Pharmaceuticals, Inc.1$19
Melinta Therapeutics, LLC1$18
TriSalus Life Sciences, Inc.1$17
Ipsen Biopharmaceuticals, Inc1$15

Products named: TERLIVAZ, XIFAXAN, REZDIFFRA, VISTASEAL, OCALIVA, Rezzayo, TRINAV INFUSION SYSTEM, IQIRVO.

Industry payments across GA — which companies pay providers there.